Last $113.52 USD
Change Today +0.43 / 0.38%
Volume 2.5M
MON On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 1:22 PM 08/1/14 All times are local (Market data is delayed by at least 15 minutes).

monsanto co (MON) Key Developments

Monsanto Mulls Acquisitions

Monsanto Company (NYSE:MON) announced a fixed-income offering. Monsanto intend to use the net proceeds we receive from the sale of the securities for general corporate purposes, which may include reducing or refinancing borrowings, meeting working capital needs, capital expenditures, and acquisitions.

Monsanto Enters into One Season, Non-Exclusive Agency Agreement with Agrium to Offer the Use of Monsanto's Climate Pro Platform

Agrium Inc. announced that Monsanto has entered into a one season, non-exclusive agency agreement with Agrium to offer the use of Monsanto's Climate Pro platform to Crop Production Service's grower customers. The Climate Pro technology will complement CPS's existing comprehensive precision agriculture products and services offering, known as Echelon.

Monsanto Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended May 31, 2014; Raises Earnings Guidance for the Full Year of 2014

Monsanto Company announced unaudited consolidated earnings results for the third quarter and nine months ended May 31, 2014. For the quarter, the company announced total net sales of $4,250 million compared to $4,248 million for the same period a year ago. Income from operations was $1,249 million compared to $1,238 million for the same period a year ago. Income from continuing operations before income taxes was $1,221 million compared to $1,224 million for the same period a year ago. Income from continuing operations including portion attributable to non controlling interest was $880 million or $1.64 per diluted share compared to $932 million or $1.70 per diluted share for the same period a year ago. Net income attributable to the company was $858 million or $1.62 per basic and diluted share compared to $909 million or $1.68 per diluted share for the same period a year ago. EBIT was $1,211 million compared to $1,204 million for the same period a year ago. For the nine months, the company announced net sales of $13,225 million compared to $12,659 million for the same period a year ago. Income from operations was $4,232 million compared to $3,859 million for the same period a year ago. Income from continuing operations before income taxes was $4,077 million compared to $3,770 million for the same period a year ago. Income from continuing operations including portion attributable to non controlling interest was $2,912 million or $5.49 per diluted share compared to $2,753 million or $5.09 per diluted share for the same period a year ago. Net income attributable to the company was $2,896 million or $5.45 per diluted share compared to $2,731 million or $5.05 per diluted share for the same period a year ago. EBIT was $4,128 million compared to $3,790 million for the same period a year ago. Net cash provided by operating activities was $371 million compared to $786 million for the same period a year ago. Capital expenditures were $688 million compared to $459 million for the same period a year ago. The company raised its full year of 2014 guidance to the upper end of its previous guidance ranges, with ongoing EPS guidance of $5.10 to $5.20, positioning the company for strong growth for the full year. Full-year EPS guidance on an as-reported basis is expected in the range of $5.12 to $5.22 per share. Updated EPS guidance continues to incorporate the effects related to agricultural industry headwinds, including an estimated $0.15 to $0.20 full-year EPS effect, largely related to currency fluctuations. The company also increased its full year free cash flow outlook to the upper end of previous guidance, at $700 million to $800 million. The free cash flow guidance is inclusive of the cash used for the company’s fiscal year 2014 acquisition of the Climate Corporation and recent bioag alliance with Novozymes.  The company expects net cash provided by operating activities to be $2.9 billion to $3.3 billion, and net cash required by investing activities to be approximately $2.2 billion to $2.5 billion for fiscal year 2014, including capital expenditures and acquisition-related costs.

Syngenta And Monsanto Are Reportedly In Takeover Talk

Syngenta AG (SWX:SYNN) saw shares jump yesterday, after a report it had been in talks about a $40 billion takeover by Monsanto Company (NYSE:MON). Monsanto and Syngenta had held preliminary talks about combining according to a report from Bloomberg. The talks were later abandoned, the report said. A Syngenta spokesman declined to comment on the report and Monsanto was not immediately available for comment.

Monsanto Company to Report Q3, 2014 Results on Jun 25, 2014

Monsanto Company announced that they will report Q3, 2014 results at 9:00 AM, Eastern Standard Time on Jun 25, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MON:US $113.52 USD +0.43

MON Competitors

Market data is delayed at least 15 minutes.

Company Last Change
EI du Pont de Nemours & Co $64.18 USD -0.13
FMC Corp $65.44 USD +0.22
Sumitomo Chemical Co Ltd ¥387.00 JPY -10.00
Syngenta AG SFr.324.60 CHF +2.40
Dow Chemical Co/The $50.91 USD -0.16
View Industry Companies
 

Industry Analysis

MON

Industry Average

Valuation MON Industry Range
Price/Earnings 22.9x
Price/Sales 3.8x
Price/Book 4.0x
Price/Cash Flow 22.4x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MONSANTO CO, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.